Strategies for overcoming the blood-brain barrier for the treatment of brain metastases (Q38233077)

30 June 2019

title

Strategies for overcoming the blood-brain barrier for the treatment of brain metastases (English)

1 reference

30 June 2019

1 reference

Jethro Hu

1

1 reference

30 June 2019

Santosh Kesari

series ordinal

2

1 reference

30 June 2019

publication date

1 January 2013

1 reference

30 June 2019

published in

CNS oncology

1 reference

30 June 2019

volume

2

1 reference

30 June 2019

issue

1

1 reference

30 June 2019

page(s)

87-98

1 reference

30 June 2019

Drug interactions at the blood-brain barrier: fact or fantasy?

cites work

1 reference

Electrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study

21 January 2018

1 reference

Delivery of chemotherapy and antibodies across the blood-brain barrier and the role of chemoprotection, in primary and metastatic brain tumors: report of the Eleventh Annual Blood-Brain Barrier Consortium meeting

21 January 2018

1 reference

The blood-brain barrier and cancer: transporters, treatment, and Trojan horses

21 January 2018

1 reference

Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells.

21 January 2018

1 reference

Glioblastoma stem-like cells give rise to tumour endothelium.

21 January 2018

1 reference

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

21 January 2018

1 reference

Blood-brain barrier drug targeting: the future of brain drug development

21 January 2018

1 reference

Breast cancer metastasis to the central nervous system

21 January 2018

1 reference

Lapatinib distribution in HER2 overexpressing experimental brain metastases of breast cancer.

21 January 2018

1 reference

Heterogeneous Blood–Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer

21 January 2018

1 reference

Effect of blood brain barrier permeability in recurrent high grade gliomas on the intratumoral pharmacokinetics of methotrexate: a microdialysis study

21 January 2018

1 reference

"Pulsatile" high-dose weekly erlotinib for CNS metastases from EGFR mutant non-small cell lung cancer.

21 January 2018

1 reference

Outwitting the Blood-Brain Barrier for Therapeutic Purposes: Osmotic Opening and Other Means

21 January 2018

1 reference

Etoposide with or without mannitol for the treatment of recurrent or primarily unresponsive brain tumors: a Children's Cancer Group Study, CCG-9881.

21 January 2018

1 reference

Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in the treatment of cerebral metastasis

21 January 2018

1 reference

Radionuclide assessment of blood-brain barrier disruption performed for chemotherapy of high grade malignant brain gliomas

21 January 2018

1 reference

Bradykinin increases blood-tumor barrier permeability by down-regulating the expression levels of ZO-1, occludin, and claudin-5 and rearranging actin cytoskeleton

21 January 2018

1 reference

Bradykinin selectively opens blood-tumor barrier in experimental brain tumors

21 January 2018

1 reference

Intra-arterial Cereport (RMP-7) and carboplatin: a dose escalation study for recurrent malignant gliomas

21 January 2018

1 reference

Differential effects of nitric oxide on blood-brain barrier integrity and cerebral blood flow in intracerebral C6 gliomas

21 January 2018

1 reference

PDE5 inhibitors enhance tumor permeability and efficacy of chemotherapy in a rat brain tumor model

21 January 2018

1 reference

Phosphodiesterase type 5 inhibitors increase Herceptin transport and treatment efficacy in mouse metastatic brain tumor models

21 January 2018

1 reference

A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants

21 January 2018

1 reference

Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study

21 January 2018

1 reference

A phase II study of the MDR inhibitor biricodar (INCEL, VX-710) and paclitaxel in women with advanced ovarian cancer refractory to paclitaxel therapy

21 January 2018

1 reference

Phase II study of tariquidar, a selective P-glycoprotein inhibitor, in patients with chemotherapy-resistant, advanced breast carcinoma

21 January 2018

1 reference

A randomized, placebo-controlled, double-blind phase 2 study of docetaxel compared to docetaxel plus zosuquidar (LY335979) in women with metastatic or locally recurrent breast cancer who have received one prior chemotherapy regimen

21 January 2018

1 reference

Brain distribution and bioavailability of elacridar after different routes of administration in the mouse

21 January 2018

1 reference

Blood-brain barrier transport of cationized immunoglobulin G: enhanced delivery compared to native protein

21 January 2018

1 reference

Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles

21 January 2018

1 reference

The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells

21 January 2018

1 reference

Inhibition of transferrin iron release increases in vitro drug carrier efficacy

21 January 2018

1 reference

Intratumoral therapy of glioblastoma multiforme using genetically engineered transferrin for drug delivery.

21 January 2018

1 reference

Polymalic acid-based nanobiopolymer provides efficient systemic breast cancer treatment by inhibiting both HER2/neu receptor synthesis and activity

21 January 2018

1 reference

Inhibition of brain tumor growth by intravenous poly(β- l -malic acid) nanobioconjugate with pH-dependent drug release

21 January 2018

1 reference

Frontiers in cancer nanomedicine: directing mass transport through biological barriers

21 January 2018

1 reference

Boosting Brain Uptake of a Therapeutic Antibody by Reducing Its Affinity for a Transcytosis Target

21 January 2018

1 reference

Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastoma

21 January 2018

1 reference

Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer

21 January 2018

1 reference

Uptake of ANG1005, a novel paclitaxel derivative, through the blood-brain barrier into brain and experimental brain metastases of breast cancer

21 January 2018

1 reference

Luteinizing Hormone-Releasing Hormone (LHRH)-I antagonist cetrorelix inhibits myeloma cell growth in vitro and in vivo

21 January 2018

1 reference

Effects of adrenal cortical steroids and osmotic blood-brain barrier opening on methotrexate delivery to gliomas in the rodent: the factor of the blood-brain barrier

21 January 2018

1 reference

Vemurafenib for Melanoma Metastases to the Brain

21 January 2018

1 reference

The distribution of secondary growths in cancer of the breast. 1889

21 January 2018

1 reference

Genes that mediate breast cancer metastasis to the brain

21 January 2018

1 reference

Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors

21 January 2018

1 reference

A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma

21 January 2018

1 reference

12 December 2020

A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs

1 reference

12 December 2020

Astrocytes contribute to the brain-metastatic specificity of melanoma cells by producing heparanase

1 reference

12 December 2020

Toxicity and efficacy of carboplatin and etoposide in conjunction with disruption of the blood-brain tumor barrier in the treatment of intracranial neoplasms

1 reference

12 December 2020

The biology of brain metastases-translation to new therapies

1 reference

12 December 2020

Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720.

1 reference

12 December 2020

Verapamil increases the survival of patients with anthracycline-resistant metastatic breast carcinoma

1 reference

12 December 2020

Phase III study of valspodar (PSC 833) combined with paclitaxel and carboplatin compared with paclitaxel and carboplatin alone in patients with stage IV or suboptimally debulked stage III epithelial ovarian cancer or primary peritoneal cancer

1 reference

12 December 2020

Non-AIDS primary CNS lymphoma: first example of a durable response in a primary brain tumor using enhanced chemotherapy delivery without cognitive loss and without radiotherapy.

1 reference

12 December 2020

Identifiers

DOI

10.2217/CNS.12.37

1 reference

30 June 2019

PMC publication ID

6169493

1 reference

30 June 2019

PubMed publication ID

25054359

1 reference

30 June 2019